27 July 2018
Fiona Thomson GPNZ Level 2 88 The Terrace Wellington 6011 Dear Fiona, As you may be aware from 1 August 2018 rivaroxaban (in 10 mg, 15 mg and 20 mg) will be funded without a Special Authority. Note: the 10 mg tablet will have a restriction limiting the dose to one tablet per day. Information for health professionals and consumers Some recently developed resources for health care professional and consumers to learn about the safe and appropriate use of rivaroxaban include: •
BPACnz article: Rivaroxaban: a fully-subsidised oral anticoagulant
•
PHARMAC Seminar online: Anticoagulation update
It is important people understand how to safely take rivaroxaban. The Health Navigator website have produced consumer information on rivaroxaban, including a downloadable leaflet, which may be useful in discussions with patients. We think this information may be of value to your members and would appreciate it if you could share this information with them. Kind regards,
Dr Bryan Betty Deputy Medical Director
A1165816 -